Mirvie was founded by Maneesh Jain, Stephen Quake.

Who are Mirvie's investors?

Mirvie's investors include Decheng Capital, Mayfield Fund, Portfolia, Foresite Capital, General Catalyst, Khosla Ventures.

How much funding has Mirvie raised?

Mirvie has disclosed $23.7M raised across 1 round.

Where is Mirvie headquartered?

Mirvie is headquartered in South San Francisco, US.

Mirvie

South San Francisco, US · Delaware corporation · 6 known investors

mirvie.com ↗

Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical. The platform serves pregnant women and their healthcare providers to improve maternal and fetal health outcomes.

BiotechFemTechHealthtech

Founders & leadership

Maneesh JaininCEO & Co-founder

Stephen QuakeCo-founder

Board

Lisa IversonBoard director

Ursheet Parikh in 𝕏Board directorInvestor in AI, Enterprise Infrastructure, and Human & Planetary Health at Mayfield

Min CuiBoard directorFounder and Managing Director at Decheng Capital

Samir Kaul in 𝕏Board MemberInvestor at Khosla Ventures

Naomi KelmaninBoard director

Stanley LapidusinBoard director

Investors · 6

Decheng CapitalMenlo Park

Mayfield FundCupertino · $500K – $12M

PortfoliaSan Mateo

Foresite CapitalreportedLarkspur

General CatalystreportedSan Francisco · $30M

Khosla VenturesreportedMenlo Park · $5K – $50M

Reported raises · per SEC filings

Form D private placements

$23.7M disclosed across 1 round · 2025

▶$23.7MraisedAug 2025 · 25 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Lisa IversonDirector
Ursheet ParikhDirector
Naomi KelmanDirector
Min CuiDirector
Maneesh JainExecutive Officer, Director, Promoter
Stanley LapidusDirector
Samir KaulDirector
Stephen QuakeDirector

Offering amount: $30M
Amount sold: $23.7M
First sale: Jul 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Mirvie Inc. raises $23.7M: offering $30M: Form Dainvest.com · Aug 2025

Biotech Company Mirvie Raises $60M for Its RNA Platform Focused on Early Prediction of Pregnancy Complications | Femtech Insiderfemtechinsider.com · May 2022

Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complicationsforbes.com · May 2022

Wilson Sonsini Advises Mirvie on $60 Million Series B | Wilson Sonsiniwsgr.com · May 2022

Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Healthbusinesswire.com · May 2022

Frequently asked questions

What does Mirvie do?: Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical. The platform serves pregnant women and their healthcare providers to improve maternal and fetal health outcomes.
Who founded Mirvie?: Mirvie was founded by Maneesh Jain, Stephen Quake.
Who are Mirvie's investors?: Mirvie's investors include Decheng Capital, Mayfield Fund, Portfolia, Foresite Capital, General Catalyst, Khosla Ventures.
How much funding has Mirvie raised?: Mirvie has disclosed $23.7M raised across 1 round.
Where is Mirvie headquartered?: Mirvie is headquartered in South San Francisco, US.